Sex-Specific Genetic Associations for Barrett's Esophagus and Esophageal Adenocarcinoma
Overview
Authors
Affiliations
Background & Aims: Esophageal adenocarcinoma (EA) and its premalignant lesion, Barrett's esophagus (BE), are characterized by a strong and yet unexplained male predominance (with a male-to-female ratio in EA incidence of up to 6:1). Genome-wide association studies (GWAS) have identified more than 20 susceptibility loci for these conditions. However, potential sex differences in genetic associations with BE/EA remain largely unexplored.
Methods: Given strong genetic overlap, BE and EA cases were combined into a single case group for analysis. These were compared with population-based controls. We performed sex-specific GWAS of BE/EA in 3 separate studies and then used fixed-effects meta-analysis to provide summary estimates for >9 million variants for male and female individuals. A series of downstream analyses were conducted separately in male and female individuals to identify genes associated with BE/EA and the genetic correlations between BE/EA and other traits.
Results: We included 6758 male BE/EA cases, 7489 male controls, 1670 female BE/EA cases, and 6174 female controls. After Bonferroni correction, our meta-analysis of sex-specific GWAS identified 1 variant at chromosome 6q11.1 (rs112894788, KHDRBS2-MTRNR2L9, P = .039) that was statistically significantly associated with BE/EA risk in male individuals only, and 1 variant at chromosome 8p23.1 (rs13259457, PRSS55-RP1L1, P = 0.057) associated, at borderline significance, with BE/EA risk in female individuals only. We also observed strong genetic correlations of BE/EA with gastroesophageal reflux disease in male individuals and obesity in female individuals.
Conclusions: The identified novel sex-specific variants associated with BE/EA could improve the understanding of the genetic architecture of the disease and the reasons for the male predominance.
Ge Y, Lin X, He J, Chen W, Lin D, Zheng Y Diagn Pathol. 2024; 19(1):15.
PMID: 38243319 PMC: 10797953. DOI: 10.1186/s13000-024-01439-8.
Proteome Profiling of Brain Vessels in a Mouse Model of Cerebrovascular Pathology.
Haqqani A, Mianoor Z, Star A, Detcheverry F, Delaney C, Stanimirovic D Biology (Basel). 2023; 12(12).
PMID: 38132326 PMC: 10740654. DOI: 10.3390/biology12121500.
Prognosis prediction in esophageal signet-ring-cell carcinoma: a competing risk analysis.
Chen C, Wang Z, Qin Y BMC Gastroenterol. 2023; 23(1):178.
PMID: 37221531 PMC: 10207763. DOI: 10.1186/s12876-023-02818-z.
Alcohol Use and Use Disorder and Cancer Risk: Perspective on Causal Inference.
Zhou H, Vasiliou V Complex Psychiatry. 2023; 8(1-2):9-12.
PMID: 36601413 PMC: 9669948. DOI: 10.1159/000526407.
Today's Mistakes and Tomorrow's Wisdom in Development and Use of Biomarkers for Barrett's Esophagus.
Frei N, Stachler M Visc Med. 2022; 38(3):173-181.
PMID: 35814971 PMC: 9210037. DOI: 10.1159/000521706.